The role of alpha defensins in patients with ankylosing spondylitis

Basit Öğe Kaydı
dc.authorid0000-0001-9740-5407en_US
dc.authorid0000-0002-5780-5569en_US
dc.contributor.authorOktayoğlu, Pelin
dc.contributor.authorMete, Nuriye
dc.contributor.authorÇaǧlayan, Mehmet
dc.date.accessioned2023-10-25T07:45:41Z
dc.date.available2023-10-25T07:45:41Z
dc.date.issued2021en_US
dc.departmentDicle Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Fizik Tedavi ve Rehabilitasyon Ana Bilim Dalıen_US
dc.description.abstractObjectives Defensins are a family of antimicrobial peptides. Elevated levels of human neutrophil peptides (HNP 1-3) are seen in blood samples of patients with inflammatory bowel disease (IBD) and in many rheumatic diseases. It has been suggested that they may play a significant role in the progression and pathogenesis of these diseases. Therefore, we aimed to investigate the levels of HNP 1-3 in sera of patients with ankylosing spondylitis (AS) and its association with disease activity and other clinical features of AS. Methods A total of 36 patients, who met the Modified New York Criteria for AS, and 50 healthy controls (HCs) were included in this study. The Bath AS Disease Activity Index (BASDAI) and the Ankylosing Spondylitis Disease Activity Score (ASDAS) were used to assess disease activity. The Bath AS Radiology Index (BASRI) was used to assess radiological damage. Spinal and hip measurements were determined by the Bath AS Metrology Index (BASMI). An AS Quality of Life (ASQoL) questionnaire was administered to assess the disease-related quality of life. Serum HNP 1-3 levels were determined using the ELISA kit. Results Mean serum HNP 1-3 levels were significantly higher in patients with AS (287.01±201.307 vs. 152.09±43.75 pg/ml) compared with HCs (p=0.001). HNP 1-3 levels did not correlate with BASDAI (p=0.519), ASDAS-CRP (p=0.424), BASRI (p=0.280), BASMI (p=0.168), ASQoL (p=0.307), ESR (p=0.706) and CRP (p=0.157) values. Conclusion Elevated serum levels of HNP 1-3 may play an important role in the pathogenetic mechanisms of AS. This result may give us an opportunity to develop new treatment strategies considering the role of these peptides in the pathogenetic mechanisms of AS.en_US
dc.identifier.citationOktayoğlu, P., Mete, N. ve Çağlayan, M. (2021). The role of alpha defensins in patients with ankylosing spondylitis. Aktuelle Rheumatologie, 46(2), 198-203.en_US
dc.identifier.doi10.1055/a-1242-4217
dc.identifier.endpage203en_US
dc.identifier.issn0341-051X
dc.identifier.issue2en_US
dc.identifier.scopus2-s2.0-85092744738
dc.identifier.scopusqualityQ4
dc.identifier.startpage198en_US
dc.identifier.urihttps://www.thieme-connect.de/products/ejournals/pdf/10.1055/a-1242-4217.pdf
dc.identifier.urihttps://hdl.handle.net/11468/12927
dc.identifier.volume46en_US
dc.identifier.wosWOS:000575608900001
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.institutionauthorOktayoğlu, Pelin
dc.institutionauthorMete, Nuriye
dc.institutionauthorÇağlayan, Mehmet
dc.language.isoenen_US
dc.publisherGeorg Thieme Verlagen_US
dc.relation.ispartofAktuelle Rheumatologie
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectHumane neutrophile Peptide 1-3en_US
dc.subjectKrankheitsaktivitäten_US
dc.subjectSpondylitis ankylosansen_US
dc.titleThe role of alpha defensins in patients with ankylosing spondylitisen_US
dc.titleThe role of alpha defensins in patients with ankylosing spondylitis
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
The Role of Alpha Defensins in Patients.pdf
Boyut:
257.8 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Makale Dosyası
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Dahili Tıp Bilimleri Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu